Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3
Closed -$7 4927
2025
Q2
$7 Buy
+3
New +$7 ﹤0.01% 4883
2025
Q1
Hold
0
4265
2024
Q4
Hold
0
4557

IFP Advisors's SLRN Position: Q3 2025 in Review

IFP Advisors sold out of ACELYRIN (SLRN) in Q3 2025, closing a stake of 3 shares — an estimated $7 sold.

IFP Advisors first reported a position in SLRN in Q2 2025 and held it in 1 quarter. The position peaked at $7 in Q2 2025. 0 funds tracked by Wall St. Rank hold SLRN as of Q3 2025.

  • IFP Advisors reported no remaining ACELYRIN position as of Q3 2025 after selling out during the quarter.
  • IFP Advisors sold 3 ACELYRIN shares in Q3 2025, an estimated $7.
  • IFP Advisors first reported a position in ACELYRIN in Q2 2025 and held it in 1 quarter.
  • IFP Advisors's ACELYRIN position peaked at $7 in Q2 2025.
  • 0 funds tracked by Wall St. Rank held ACELYRIN as of Q3 2025.

Based on IFP Advisors's 13F filing for Q3 2025, filed 2 Dec 2025.